Back to search

Article

Reducing VEGFB accelerates NAFLD and insulin resistance in mice via inhibiting AMPK signaling pathway

2022-06-13

Abstract excerpt

<h4>Objective: </h4> Vascular endothelial growth factor B (VEGFB) was regarded to improve lipid metabolism and reduce obesity-related hyperlipidemia. Whether VEGFB participates in lipid metabolism in nonalcoholic fatty liver disease (NAFLD) has not been clear yet. This study investigated the involvement of VEGFB in lipid metabolism and insulin resistance via the AMPK signaling pathway in NAFLD. <h4>Methods: </h4>:...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7c2507de-5601-5272-86fe-38a47e3434b2
DOI
10.21203/rs.3.rs-1695906/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Reducing VEGFB accelerates NAFLD and insulin resistance in mice via inhibiting AMPK signaling pathwayDOI 10.21203/rs.3.rs-1695906/v1
Select a neighboring publication to make it the new centre.